APACHE, Acute Physiology and Chronic Health Evaluation; HDU, high dependency unit; IQR, interquartile range. | |
*Early: failure within 48 hours of NIV; †Late: failure after 48 hours of NIV. | |
Successful trials, number and % | 121 (60.5%) |
Failures, number and % | 79 (39.5%) |
Intolerance | 16 (8%) |
Inefficacy: | |
Early* | 52 (26%) |
Late† | 11 (5.5%) |
Intubation, number and % | 13 (6.5%) |
Tracheostomy, number and % | 2 (1%) |
HDU mortality, number (and %) of patients | 52 (27.4%) |
Global mortality, number (and %) of patients | 68 (34.5%) |
Mortality predicted by APACHE II | 32% |
HDU length of stay, median days (IQR) | 6 (3–10) |
Hospital length of stay, median days (IQR) | 15 (8–26) |